Actinic DNA Damage and the Pathogenesis of Cutaneous Malignant Melanoma  by Ross, Peter Maimon & Carter, D Martin
Actinic DNA Damage and the Pathogenesis of 
Cutaneous Malignant Melanoma 
Peter Maimon Ross, Ph.D., and D. Martin Carter, M.D., Ph.D. 
The Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York, U.S.A. 
The near epidemic of melanoma and non-melanoma skin 
cancer in the United States and certain other industrialized 
nations is attributable to cutaneous exposure to sunlight more 
than to any other factor. Chronic exposure to UV irradiation 
and a high total cumulative dose may be less deleterious than 
are periodic bursts of large amounts of sun exposure leading 
to severe sunburn. Such an exposure pattern is characteristic 
of individuals such as office workers whose outdoor activities 
are irregular rather than daily, as with farmers or fishermen. 
Although UV irradiation is injurious to many cellular ele­
ments, the mechanisms underlying UV -mediated skin cancer 
are thought to be most likely related to DNA damage to 
cutaneous cells. Various types ofUV-induced DNA damage 
have been identified, and they differ in biologic significance. 
Damage which is apt to be most cytotoxic is probably less 
S olar ultraviolet radiation (UV) is a mutagen and a carcino­gen. Many intracellular and extracellular chemical reac­tions are caused by the interaction of UV with human skin. These reactions generate photoproducts of proteins and DNA. The consequences of such alterations include 
altered function, mutagenesis, and cell death. It is widely thought 
that genetic alterations consequent to UV exposure are a required 
step in UV carcinogenesis. DNA repair and melanin are the best 
characterized defenses against actinic damage in the skin. Each 
functions to minimize the potential genotoxicity and mutagenicity 
of UV exposure. Here we will first illustrate important features of 
the repair of UV damaged DNA in the skin using the bacterial 
paradigms upon which much current thinking is based. We will 
then review recent literature pertinent to UV effects on the melano­
cyte that may underlie cutaneous malignant melanoma. The inter­
ested reader is referred to selected reviews on the enzymology of 
DNA repair [1-6] and its consequences [7,8]. 
The existence of DNA repair remained unknown until the late 
1950s, when Hill found that certain strains of E. coli were much 
more sensitive to killing by sunlight than others. Several years later, 
two groups simultaneously showed that the UV-sensitive strains 
were defective in the release from their DNA of a UV photoproduct 
that was ultimately identified as the pyrimidine dimer, which is 
formed by cycloaddition of two adjacent pyrimidines at the 5,6 
unsaturated bond. These strains were designated "uvr" mutants. 
The endonuclease itself is coded by three genes; exonuclease activity 
was required to clear a gap around the lesion; a DNA polymerase 
then filled in the gap; and polynucleotide ligase completed the 
repair process by resealing the nick left by polymerase action on the 
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effective as an inducer of skin cancer than is more subtle 
damage, which is tolerated but can initiate malignant trans­
formation. 
Repair of DNA damage involves specific cellular activities 
which vary in their effectiveness in restoring cutaneous cell 
function to normal. Other biologic effects of UV irradiation 
may contribute to the development of skin cancer through 
effects on such defenses as pigmentation and the immune 
response. Sun-induced damage to DNA, however, is appar­
ently necessary. Biologic consequences of dangerous envi­
ronmental exposure to UV irradiation can be modulated by 
changes in life-style, the depth of the ozone layer, use of 
sunscreens, and possibly by hormones or their synthetic ana­
logs.] Invest DermatoI92:293S-296S, 1989 
gap. The product was damage-free and identical in sequence to the 
DNA prior to damage. This "excision repair" process has now been 
well characterized at the molecular level. Coeval with the discovery 
of the pryrimidine dimer, Clark isolated a mutant of E. coli that was 
somewhat UV-sensitive and also failed to assimilate new DNA by 
genetic recombination. Although numerous other "Rec" genes 
were identified, recA gene defects alone conferred the total absence 
of recombination. Post-replication gaps occur in DNA when a rep­
lication fork passes a dimer. Rupp and co-workers showed that the 
UV sensitivity in E. coli recA was due to a failure in a post-replication 
gap-filling process that later became known as "recombination re­
pair," which redistributes damages between daughter strands, so 
that they become diluted out in subsequent generations. The recA 
gene is pleiotropic and serves to regulate the synthesis of many 
genes relevant to UV damage and repair. It is "activated" in UV -ir­
radiated cells to a form that increases both survival and mutagenesis 
of the cells or infecting viruses. This "error-prone repair" was tan­
talizing as a possible model for mutation and carcinogenesis in man, 
particularly because recA mutants were not mutable by UV expo­
sure. Activated recA protein also is a protease that cleaves the lambda 
repressor, causing prophage induction. The numerous enzymes and 
potential outcomes of these various processes led to a proliferation 
of "pathways" schemata resembling intermediary metabolism 
charts. We now think of these processes as being in a kind of dy­
namic equilibrium: dynamic, because the physiologic state of the 
cell can influence the predominance of one particular outcome; and 
equilibrium, because various outcomes are more or less likely at any 
given lesion, depending on its location, the repair phenotype of the 
cell, and seemingly ancillary factors such as replication. 
The processes by which actinic DNA damage is repaired in 
human skin cells are manyfold more complicated than those repair­
ing similar damage in DNA of bacteria. First, there are more genes 
coding for crucial functions; second, chromatin architecture com­
plicates repair enzyme action; third, we are no longer dealing with 
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ageless cells in a virtual chemostat, but with cells at a given stage of 
an individual's life, and in the milieu of various hormones and 
chalones that vary with the individual's physiologic state. In brief, 
we have not yet achieved a molecular understanding of DNA repair 
in human cells. However, many phenomena resembling those seen 
in prokaryotes are detected. 
DNA repair responses Normal, cultured fibroblasts and kerati­
nocytes have been studied extensively for the ability to remove 
pyrimidine dimers from DNA. Most workers have detected rapid 
and slow components to the exonuclease action [9]. Cells from 
patients suffering from xeroderma pigmentosum (XP) approximate 
the slow component [10]. However, XP may also confer a general 
defect in chromosome structure that predisposes to carcinogenesis 
in a nonspecific manner [11]. Nondividing, cultured cells remove 
about 1 (fast component) to 0.1 (slow component) dimer per 70 
kilobase pairs DNA per day. Lethality occurs in the range of 1 dimer 
per 15 kilobase pairs DNA, a yield produced by, e.g., 20 Jjm2 of 254 
nm UV, or by about 20-fold more solar UVB. Dividing cultured 
cells with doubling times in the range of 24 to 48 h apparently 
tolerate considerable damage in their 0 N A. Similar levels of 0 N A 
repair have been detected in cultured fibroblasts and keratinocytes 
[12], in fibroblasts from young or aged individuals [13], in keratino­
cytes from sun-damaged or protected skin [14], and in cultured 
fibroblasts, whether SV 40-transformed or normal [15]. Apparently, 
excision repair in skin fibroblasts and keratinocytes from genetically 
normal individuals occurs independent of environmental exposure, 
age, or neoplastic transformation. In contrast, excision repair com­
petence in melanoma cells or cells from melanoma patients is nor­
mal [16]' slightly reduced [17], or variable [18] when compared 
with cells from normal individuals, suggesting a genetic defect of 
excision repair in melanoma-prone individuals. Cells from some 
patients with dysplastic nevus syndrome are hypermutable in vitro 
[19]. Mouse melanomas exhibit elevated postreplication repair in 
vitro [20], consistent with the phenotype of hyper mutability [21]. It 
should be emphasized in this context that DNA excision repair in 
nocturnal rodents such as mice differs from that in diurnal animals 
and humans. Mouse cultured cells repair pyrimidine dimers at rates 
similar to those seen in cells from XP patients, yet they tolerate 
levels ofUV exposure similar to normal human cells [22]. Interest­
ingly, the mouse [23] and hamster [24] model systems for melano­
magenesis bear a keen resemblance to rodent models for skin carci­
noma in that precursor lesions are readily apparent. 
Direct evidence of the lesion responsible for some cancers was 
obtained in experiments with thyroid cells from the molly Poecilia. 
UV -irradiated cells placed in syngeneic recipient fish developed 
into tumors. Photoreactivation (exposure to intense, white light) 
reversed both the dimers [25] and the cancer phenotype in the 
transplanted cells [26]. Photoreactivation reverses no other known 
lesion [27], including the pyrimidine (6,4) pyrimidone photoprod­
uct [28]. This latter product has been implicated as an important 
premutagenic lesion in several systems. However, it has been diffi­
cult to discern its effects from those of the pyrimidine dimer, partly 
because the action spectra for the two photoproducts overlap [29]. 
The data for Poecilia may be construed as evidence that the pyrim­
idine dimer is a DNA photoproduct that can cause carcinoma. How­
ever, less is known about the pathogenesis of melanoma which, in 
its invasive and immunologic properties as well as the developmen­
tal origin of its precursor cells, resembles neuroblastoma more 
closely than it does skin carcinoma. It is therefore useful to consider 
other effects of UV, as they may be important in the neoplastic 
transformation of melanocytes. In addition to base injury, UV 
causes indirect damage to DNA and other cellular constituents by 
oxidation. Some of this damage is the indirect result of inflamma­
tion that occurs in irradiated skin [30]. However, another part of the 
damage is a direct consequence of irradiation [31]. While other 
potential targets such as membranes exist, DNA is an important site 
for oxidative damage. Oxidative damage, secondary to ionizing 
radiation, is a major source for the nicks and breaks in DNA exposed 
to this modality. Although UV is less energetic than ionizing radia-
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tion, it can interact with cellular molecules, among them riboflavin, 
to generate reactive oxygen [32]. The main sink for reactive oxygen 
in skin is reducing equivalents in cellular glutathione (GSH). In 
cultured cells exposed to simulated solar UV, lethality was en­
hanced significantly by GSH deprivation [33]. Solar UV also de­
pletes cutaneous GSH [34]. However, mutagenic or carcinogenic 
effects ofUV oxidation have not been demonstrated directly. Inter­
estingly, GSH levels increase in many tumors and may be elevated 
in melanoma [35]. 
In view of the possible role of oxidation in the genesis of mela­
noma, it is useful to consider melanocyte chemistry. Much of the 
catechol oxidation chemistry in melanogenesis resembles the meta­
bolic activation of chemical carcinogens by cytochrome P450 en­
zymes found in the liver and in epidermal keratinocytes [36]. This 
led to the suggestion [37] that carcinogens peculiar to pheomelano­
genesis [38,39] may lead to UV -catalyzed autocarcinogenesis. This 
hypothesis does not explain the peculiar anatomic distribution of 
the tumor. However, it is consistent with the fivefold higher popu­
lation risk for melanoma in white as distinct from black Americans 
[40]. Also, the occupational association between PCB [41] or refin­
ery [42] exposure and melanoma suggests that the induction of 
particular cytochrome P450 species in the melanocyte may favor 
metabolic formation of ultimate carcinogens from normal melano­
cyte components. Although one test for an association between 
acetylator phenotype and melanoma susceptibility was negative 
[43], the P450 enzymes are probably too complex for a broad con­
clusion to be drawn from negative data. 
Cellular Responses Normal, cycling, cultured fibroblasts ex­
posed to DNA damaging agents accumulate in late G1jG2 arrest 
[44]; the MSH receptor is most abundant on the cell surface at this 
stage of the cell cycle. This can partly explain tanning in UV-ex­
posed skin. However, in addition to this and the immediate tanning 
response, there is a direct induction of melanogenesis in UV-irra­
diated melanocytes in culture [45]. Moreover, a fraction of the mela­
nocytes die in UV-irradiated, tanning-competent rodent skin [46]. 
It remains uncertain how many melanocytes appearing in the hy­
perpopulated skin resulting from the exposure are survivors and 
how many repopulate from elsewhere. One way to sort this out may 
be to perform experiments with albino mice grafted distally with 
histocompatible, pigmented skin. When considering the murine 
model, it should be remembered that melanocytes in mouse skin are 
found uniquely in hair follicles. 
It may be that some peculiarity of cell biology in susceptible 
individuals can lead to melanoma as a result of the melanocyte's 
unique proliferative response to UV exposure. Prostaglandins can 
cause melanocyte proliferation [47]. Arachidonate released from 
irradiated epidermal cells [30] could stimulate the PGE2 formation 
[47]. The proliferative response in damaged cells could fix the dam­
age in a fraction of the cells. By analogy, leukemogenesis in ataxia 
telangectasia is thought to result from the peculiar inability of the 
cells from these individuals to undergo the late SjG2 block in re­
sponse to exposure to ionizing radiation, resulting in clastogenesis 
[48]. Caffeine can mimic this effect in normal, cultured cells [49]. 
Pigmented melanoma cells are as UV -resistant as amelanotic mela­
noma cells [50]. Although other explanations are possible, this sug­
gests that the pigment-making cells are not themselves protected by 
the pigment. A further complication is that hyperthermia depresses 
cellular repair responses [51]. If indeed solar UV is the ultimate 
carcinogen in human melanoma, the conditions under which the 
UV exposure is incurred may cause heat-shock response in the epi­
dermis or, in the melanocyte, further damping repair. 
Mutagenic and Cytogenetic Consequences ofUV Damage In the shuttle 
vector system [52], UV has been shown to cause transition and 
transversion mutations, both of which can activate proto-oncogenes 
and also deletions, which may be similar to translocations in cell 
DNA. The Burkitt lymphoma is associated with characteristic 
translocations in which the enhancer for an immunoglobulin gene 
is placed next to a c-myc proto-oncogene which, as a consequence, 
is "dysregulated" [53]. Chronic infection with Epstein-Barr virus or 
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Plasmodium falciparum is thought to act as a promoter. Clastogenic 
effects ofuV radiation [54J or any number of other DNA-damag­
ing agents could lead to similar effects in melanocytes. Interest­
ingly, cytogenetic evidence suggests that translocations involving 
chromosomes 1, 6, and/or 7 may be a common feature in melanoma 
[55J, as in some other tumors. 
Finally, the relationship between prostaglandins, replication, and 
the immune system may be important in the ability of melanoma to 
slip through immune surveillance. Prostaglandin synthesis accom­
panies UV irradiation, and the inhibition of its synthesis blocks UV 
immune suppression [56J . Conceivably, the stimulation to prolifer­
ate at this specific time enhances survival of nascent tumors. Agents 
that inhibit these consequences ofUV exposure may someday be of 
value in melanoma prevention [57J. 
The possible etiologic connection of melanoma to solar UV -ex­
posure has been contested. Other DNA damage-based models for 
melanoma not invoking UV have been considered in the literature, 
including one invoking a non-solar "xenobiotic" found in equato­
rial regions [58]. and one invoking the possible role of fluorescent 
lighting in the etiology of the disease [59J. Studies in 1970s suggest­
ing the possible association of particles that appeared in the electron 
microscope to resemble retrovirus with some melanomas have not 
been widely pursued. We cannot rule out any of these possible 
etiologic agents in the pathogenesis of melanoma. We think that a 
better understanding of DNA repair and mutagenesis in melano­
cytes will help to identify the nature of the initial lesion. 
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